BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Digklia A, Voutsadakis IA. Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status. World J Exp Med 2014; 4(4): 58-67 [PMID: 25414818 DOI: 10.5493/wjem.v4.i4.58]
URL: https://www.wjgnet.com/2220-315X/full/v4/i4/58.htm
Number Citing Articles
1
Karolina Vernmark, Maria Albertsson, Bergthor Björnsson, Thomas Gasslander, Per Sandström, Xiao-Feng Sun, Annika Holmqvist. From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case reportBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1908-3
2
Donald T. Yapp, May Q. Wong, Alastair H. Kyle, Shannon M. Valdez, Jenny Tso, Andrew Yung, Piotr Kozlowski, David A. Owen, Andrzej K. Buczkowski, Stephen W. Chung, Charles H. Scudamore, Andrew I. Minchinton, Sylvia S. W. Ng. The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growthAngiogenesis 2016; 19(2): 229 doi: 10.1007/s10456-016-9503-z
3
Diana Klein. Endothelial Signaling in Vascular Dysfunction and Disease2021; : 91 doi: 10.1016/B978-0-12-816196-8.00015-1
4
King-Wah Chiu, Toshiaki Nakano, Kuang-Den Chen, Li-Wen Hsu, Chia-Yun Lai, Ching-Yin Huang, Yu-Fan Cheng, Shigeru Goto, Chao-Long Chen, Kwan Man. Repeated-Measures Implication of Hepatocellular Carcinoma Biomarkers in Living Donor Liver TransplantationPLOS ONE 2015; 10(5): e0124943 doi: 10.1371/journal.pone.0124943
5
Dietmar W. Siemann, Michael R. Horsman. Modulation of the tumor vasculature and oxygenation to improve therapyPharmacology & Therapeutics 2015; 153: 107 doi: 10.1016/j.pharmthera.2015.06.006
6
Anna Dmoszyńska, Elżbieta Starosławska, Krzysztof Giannopoulos. Terapia metronomiczna w hematoonkologii: nadzieje i faktyActa Haematologica Polonica 2015; 46(5): 353 doi: 10.1016/j.achaem.2015.10.004
7
Kai Wang, Xiao Qu, Ying Wang, Wei Dong, Hongchang Shen, Tiehong Zhang, Yang Ni, Qi Liu, Jiajun Du. The Impact of Ramucirumab on Survival in Patients with Advanced Solid Tumors: A Systematic Review and Meta-Analysis of Randomized II/III Controlled TrialsClinical Drug Investigation 2016; 36(1): 27 doi: 10.1007/s40261-015-0355-x
8
Gijung Kwak, Sung Duk Jo, Dongkyu Kim, Hyosuk Kim, Myung Goo Kim, Kwangmeyung Kim, Ick Chan Kwon, Sun Hwa Kim. Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticlesJournal of Controlled Release 2017; 267: 203 doi: 10.1016/j.jconrel.2017.08.015